Mechanistically, ApoB-containing atherogenic lipoproteins may promote endothelial dysfunction and microvascular injury, amplify systemic inflammation and lipid peroxidation, and perturb monoaminergic signaling and neuroplasticity—pathways long implicated in depression. This evidence concerns the gene APOB and depressive symptom measurement.